Julia Shelkey

1.3k total citations · 1 hit paper
9 papers, 956 citations indexed

About

Julia Shelkey is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Julia Shelkey has authored 9 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cancer Research. Recurrent topics in Julia Shelkey's work include Lung Cancer Treatments and Mutations (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Julia Shelkey is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Julia Shelkey collaborates with scholars based in United States. Julia Shelkey's co-authors include Howard I. Scher, David T. Hung, Charles L. Sawyers, Tomasz M. Beer, Daniel C. Danila, Celestia S. Higano, Mary‐Ellen Taplin, John L. Humm, Aseem Anand and Martin Fleisher and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Julia Shelkey

9 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

2010 809 citations Howard I. Scher, Tomasz M. Beer et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Shelkey United States	6	821	303	246	239	194	9	956
Murilo Luz Brazil	7	952 1.2×	324 1.1×	303 1.2×	173 0.7×	175 0.9×	34	1.1k
Fabian Zohren United States	14	690 0.8×	230 0.8×	197 0.8×	331 1.4×	124 0.6×	44	1.1k
Iris Kuss Germany	12	1.1k 1.4×	400 1.3×	400 1.6×	171 0.7×	224 1.2×	40	1.3k
S. Polyakov Belarus	8	811 1.0×	281 0.9×	273 1.1×	142 0.6×	153 0.8×	20	940
Giri Sulur United States	8	587 0.7×	199 0.7×	216 0.9×	104 0.4×	189 1.0×	19	796
Erik Briers Belgium	5	1.1k 1.4×	223 0.7×	445 1.8×	156 0.7×	97 0.5×	7	1.3k
Maria De Santis Austria	9	1.2k 1.5×	253 0.8×	474 1.9×	201 0.8×	109 0.6×	25	1.4k
Andrea Juliana Gomes United States	8	1.4k 1.7×	450 1.5×	496 2.0×	152 0.6×	245 1.3×	24	1.5k
Katherine Sunderland Canada	10	694 0.8×	331 1.1×	190 0.8×	161 0.7×	75 0.4×	23	761
Eren Demirhan United States	8	678 0.8×	231 0.8×	219 0.9×	201 0.8×	126 0.6×	15	955

Countries citing papers authored by Julia Shelkey

Since Specialization

Citations

This map shows the geographic impact of Julia Shelkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Shelkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Shelkey more than expected).

Fields of papers citing papers by Julia Shelkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Shelkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Shelkey. The network helps show where Julia Shelkey may publish in the future.

Co-authorship network of co-authors of Julia Shelkey

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Shelkey. A scholar is included among the top collaborators of Julia Shelkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Shelkey. Julia Shelkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Varlotto, John M., Achilles J. Fakiris, John C. Flíckinger, et al.. (2013). Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 119(15). 2683–2691. 80 indexed citations

2.

Shelkey, Julia, et al.. (2013). Case Report. Sports Health A Multidisciplinary Approach. 6(2). 145–148. 5 indexed citations

3.

Shelkey, Julia, et al.. (2012). Pretreatment serum biomarkers and clinical outcome in the phase II trial of zibotentan (endothelin A receptor antagonist) in metastatic CRPC.. Journal of Clinical Oncology. 30(5_suppl). 154–154. 2 indexed citations

4.

Andrei, Adin‐Cristian, John M. Varlotto, Julia Shelkey, et al.. (2012). Statin Use Is Associated With Decreased Local Recurrence and Improved Overall Survival in Resectable Non-small Cell Lung Cancer (NSCLC). CHEST Journal. 142(4). 925A–925A. 7 indexed citations

5.

Shelkey, Julia, Achilles J. Fakiris, Malcolm M. DeCamp, et al.. (2012). Matched-pair comparison of outcome of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.. Journal of Clinical Oncology. 30(15_suppl). 7040–7040. 3 indexed citations

6.

Varlotto, John M., Laura N. Medford‐Davis, Abram Recht, et al.. (2011). Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer. 75(3). 381–390. 31 indexed citations

7.

Varlotto, John M., Laura N. Medford‐Davis, Julia Shelkey, et al.. (2011). Surgical, histopathologic, and patient-related factors associated with isolated brain metastases (IBM) in patients with stages I-IIIA non-small cell carcinoma (NSCLC) undergoing surgical resection in comparison with patients developing other distal metastases (ODM).. Journal of Clinical Oncology. 29(15_suppl). 7542–7542. 2 indexed citations

8.

Scher, Howard I., Tomasz M. Beer, Celestia S. Higano, et al.. (2010). Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study. The Lancet. 375(9724). 1437–1446. 809 indexed citations breakdown →

9.

Scher, Howard I., Tomasz M. Beer, Celestia S. Higano, et al.. (2008). Phase I/II study of MDV3100 in patients (pts) with progressive castration-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 26(15_suppl). 5006–5006. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact